Free Trial
→ Trump wipes out trillions overnight… (From Porter & Company) (Ad) Buy HIPO Stock  Free HIPO Stock Alerts

Hippo (HIPO) Financials

Hippo logo
$28.38 -0.68 (-2.32%)
Closing price 06/20/2025 03:59 PM Eastern
Extended Trading
$28.53 +0.15 (+0.51%)
As of 06/20/2025 05:21 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for Hippo

Annual Income Statements for Hippo

This table shows Hippo's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 -142 -371 -333 -273 -41
Consolidated Net Income / (Loss)		 -141 -368 -327 -263 -29
Net Income / (Loss) Continuing Operations		 -336 -169 -327 -263 -29
Total Pre-Tax Income 		-143 -367 -325 -263 -27
Total Operating Income		 -117 -215 -328 -263 -82
Total Gross Profit		 7.00 -35 -42 -51 74
Total Revenue		 52 91 120 210 372
Operating Revenue		 52 91 120 210 372
Total Cost of Revenue		 45 126 161 261 298
Operating Cost of Revenue		 45 126 161 261 298
Total Operating Expenses		 124 180 286 212 156
Selling, General & Admin Expense		 37 49 72 80 71
Marketing Expense		 69 95 102 80 51
Research & Development Expense		 18 36 58 47 31
Restructuring Charge		 - 0.00 55 5.50 3.60
Total Other Income / (Expense), net		 -221 47 0.00 0.00 54
Other Income / (Expense), net		 -195 - 0.00 0.00 54
Income Tax Expense		 -1.80 0.70 1.30 0.50 1.20
Net Income / (Loss) Attributable to Noncontrolling Interest		 0.10 3.50 6.90 10 12
Basic Earnings per Share		 ($1.63) ($34.11) ($14.66) ($11.58) ($1.64)
Weighted Average Basic Shares Outstanding		 86.90M 10.89M 22.75M 23.58M 24.70M
Diluted Earnings per Share		 ($1.63) ($34.11) ($14.66) ($11.58) ($1.64)
Weighted Average Diluted Shares Outstanding		 86.90M 10.89M 22.75M 23.58M 24.70M
Weighted Average Basic & Diluted Shares Outstanding		 - 566.27M 23.31M 24.31M 25.08M

Quarterly Income Statements for Hippo

This table shows Hippo's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q2 2022 Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q1 2025
Period end date 6/30/2022 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 9/30/2024 3/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -74 -129 -63 -70 -108 -53 -42 -36 -8.50 -48
Consolidated Net Income / (Loss)		 -72 -128 -61 -68 -105 -50 -39 -33 -5.20 -45
Net Income / (Loss) Continuing Operations		 -72 -128 -61 -68 -105 -50 -39 -33 -5.20 -45
Total Pre-Tax Income 		-72 -127 -60 -68 -105 -51 -39 -33 -5.20 -46
Total Operating Income		 -72 -127 -61 -68 -105 -51 -40 -33 -5.20 -46
Total Gross Profit		 -18 -8.80 -3.70 -14 -48 0.90 9.50 12 21 -12
Total Revenue		 29 31 36 40 48 58 65 85 96 110
Operating Revenue		 29 31 36 40 48 58 65 85 96 110
Total Cost of Revenue		 47 40 40 54 96 57 55 73 74 123
Operating Cost of Revenue		 47 40 40 54 96 57 55 73 74 123
Total Operating Expenses		 54 119 57 54 57 52 50 45 27 33
Selling, General & Admin Expense		 18 19 18 20 22 21 18 18 15 17
Marketing Expense		 19 29 28 22 23 19 16 14 13 8.90
Research & Development Expense		 17 15 12 12 13 12 10 8.30 7.00 8.10
Other Operating Expenses / (Income)		 - - - - 0.00 0.00 - 0.00 -0.10 -0.20
Restructuring Charge		 - 55 - 0.00 0.00 0.00 5.50 3.60 0.00 0.00
Total Other Income / (Expense), net		 0.30 0.10 -1.40 0.00 0.00 0.00 - 0.00 0.00 0.00
Income Tax Expense		 0.30 0.30 0.50 0.30 0.20 -0.30 0.30 0.20 0.00 -0.20
Net Income / (Loss) Attributable to Noncontrolling Interest		 1.50 1.70 2.60 1.70 2.60 2.80 3.00 2.60 3.30 2.30
Basic Earnings per Share		 ($3.25) ($5.66) ($2.77) ($3.01) ($4.61) ($2.24) ($1.80) ($1.47) ($0.34) ($1.91)
Weighted Average Basic Shares Outstanding		 22.64M 22.84M 22.75M 23.20M 23.39M 23.73M 23.58M 24.23M 25.07M 24.98M
Diluted Earnings per Share		 ($3.25) ($5.66) ($2.77) ($3.01) ($4.61) ($2.24) ($1.80) ($1.47) ($0.34) ($1.91)
Weighted Average Diluted Shares Outstanding		 22.64M 22.84M 22.75M 23.20M 23.39M 23.73M 23.58M 24.23M 25.07M 24.98M
Weighted Average Basic & Diluted Shares Outstanding		 572.37M 23.06M 23.31M 23.26M 23.67M 23.89M 24.31M 24.43M 24.36M 25.16M

Annual Cash Flow Statements for Hippo

This table details how cash moves in and out of Hippo's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents		 450 326 -574 -49 38
Net Cash From Operating Activities		 -65 -125 -162 -92 48
Net Cash From Continuing Operating Activities		 -65 -125 -162 -92 48
Net Income / (Loss) Continuing Operations		 -141 -368 -327 -263 -29
Consolidated Net Income / (Loss)		 -141 -368 -327 -263 -29
Depreciation Expense		 6.70 11 15 20 23
Non-Cash Adjustments To Reconcile Net Income		 78 241 180 188 99
Changes in Operating Assets and Liabilities, net		 -8.20 -29 -30 -37 -46
Net Cash From Investing Activities		 -2.30 -30 -406 58 30
Net Cash From Continuing Investing Activities		 -2.30 -30 -406 58 30
Purchase of Property, Plant & Equipment		 -9.40 -14 -20 -47 -12
Purchase of Investments		 -17 -26 -793 -410 -368
Divestitures		 - - 0.00 0.00 73
Sale and/or Maturity of Investments		 108 17 409 517 337
Other Investing Activities, net		 0.00 -2.90 -2.00 -3.20 0.20
Net Cash From Financing Activities		 518 481 -6.80 -15 -40
Net Cash From Continuing Financing Activities		 518 481 -6.80 -15 -40
Repurchase of Common Equity		 - - 0.00 -1.80 -16
Payment of Dividends		 - - -5.30 -9.60 -20
Issuance of Common Equity		 - - 4.10 2.80 6.70
Other Financing Activities, net		 -1.50 482 -5.60 -6.00 -11

Quarterly Cash Flow Statements for Hippo

This table details how cash moves in and out of Hippo's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q2 2022 Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q1 2025
Period end date 6/30/2022 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 3/31/2025
Net Change in Cash & Equivalents		 -57 68 -148 -24 18 31 -74 51 -43 -17
Net Cash From Operating Activities		 -30 -43 -30 -36 -9.30 1.10 -49 18 -11 -36
Net Cash From Continuing Operating Activities		 -30 -43 -30 -36 -9.30 1.10 -49 0.00 -11 0.00
Net Income / (Loss) Continuing Operations		 -72 -128 -61 -68 -105 -50 -39 0.00 -37 0.00
Net Cash From Investing Activities		 -25 113 -115 14 35 31 -22 59 -28 -11
Net Cash From Continuing Investing Activities		 -25 113 -115 14 35 31 -22 59 -28 -11
Purchase of Property, Plant & Equipment		 -4.50 -5.50 -3.50 -3.90 -34 -4.70 -4.50 -3.40 -3.80 -2.90
Purchase of Investments		 -23 -237 -148 -111 -96 -84 -119 -55 -84 -66
Sale and/or Maturity of Investments		 2.10 355 36 130 165 119 104 117 60 58
Net Cash From Financing Activities		 -2.30 -1.10 -3.10 -1.90 -8.00 -0.90 -3.80 -8.00 -4.40 -6.00
Net Cash From Continuing Financing Activities		 -2.30 -1.10 -3.10 -1.90 -8.00 -1.00 -3.70 -8.00 -4.40 -6.00
Payment of Dividends		 - - -3.10 -0.60 -5.80 -0.10 -3.10 -7.60 -2.70 -3.50
Issuance of Common Equity		 - 0.10 0.70 0.20 1.70 0.50 0.40 1.00 1.20 1.00
Other Financing Activities, net		 -2.40 -1.20 -1.70 -1.30 -2.30 -1.40 -1.00 -1.40 -2.90 -3.50

Annual Balance Sheets for Hippo

This table presents Hippo's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Total Assets		 979 1,643 1,569 1,525 1,543
Total Current Assets		 489 841 627 287 365
Cash & Equivalents		 452 776 195 142 198
Accounts Receivable		 37 57 107 145 167
Plant, Property, & Equipment, net		 0.00 0.00 0.00 162 206
Plant, Property & Equipment, gross		 - - - 162 206
Total Noncurrent Assets		 490 802 942 1,076 973
Long-Term Investments		 56 55 121 187 168
Intangible Assets		 49 58 66 76 65
Other Noncurrent Operating Assets		 338 635 756 813 740
Total Liabilities & Shareholders' Equity		 979 1,643 1,569 1,525 1,543
Total Liabilities		 834 781 975 1,140 1,178
Total Current Liabilities		 234 516 629 696 686
Accrued Expenses		 43 95 128 114 87
Other Current Liabilities		 191 420 501 583 599
Total Noncurrent Liabilities		 600 265 346 444 492
Other Noncurrent Operating Liabilities		 327 265 346 444 492
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 -200 862 594 385 365
Total Preferred & Common Equity		 -200 860 590 378 362
Total Common Equity		 -200 860 590 378 362
Common Stock		 57 1,488 1,558 1,615 1,640
Retained Earnings		 -257 -628 -961 -1,234 -1,275
Accumulated Other Comprehensive Income / (Loss)		 0.10 -0.70 -7.00 -2.90 -2.70
Noncontrolling Interest		 0.10 2.10 3.60 6.80 3.10

Quarterly Balance Sheets for Hippo

This table presents Hippo's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2022 Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q1 2025
Period end date 6/30/2022 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 9/30/2024 3/31/2025
Total Assets		 1,629 1,630 1,605 1,681 1,647 1,496 1,545 1,540
Total Current Assets		 696 658 613 577 562 502 743 314
Cash & Equivalents		 278 347 189 200 228 223 191 141
Accounts Receivable		 67 90 134 148 145 154 158 173
Plant, Property, & Equipment, net		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 212
Plant, Property & Equipment, gross		 - - - - - - - 212
Total Noncurrent Assets		 934 972 992 1,104 1,085 994 802 1,015
Long-Term Investments		 103 109 141 136 142 163 - 175
Intangible Assets		 63 65 67 69 71 75 74 64
Other Noncurrent Operating Assets		 714 798 784 899 873 757 728 776
Total Liabilities & Shareholders' Equity		 1,629 1,630 1,605 1,681 1,647 1,496 1,545 1,540
Total Liabilities		 878 991 1,062 1,234 1,236 1,142 1,215 1,215
Total Current Liabilities		 582 661 687 798 776 705 710 730
Accrued Expenses		 121 124 133 128 125 105 98 91
Other Current Liabilities		 461 537 555 670 651 600 612 639
Total Noncurrent Liabilities		 296 330 374 436 460 436 505 485
Other Noncurrent Operating Liabilities		 296 330 374 436 460 436 505 485
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 751 639 543 447 411 355 330 326
Total Preferred & Common Equity		 749 635 538 446 407 351 326 323
Total Common Equity		 749 635 538 446 407 351 326 323
Common Stock		 1,523 1,541 1,575 1,591 1,606 1,625 1,645 1,646
Retained Earnings		 -769 -898 -1,031 -1,139 -1,192 -1,270 -1,319 -1,323
Accumulated Other Comprehensive Income / (Loss)		 -4.90 -7.80 -5.30 -6.40 -7.10 -3.40 0.50 -0.60
Noncontrolling Interest		 2.30 4.00 4.70 1.40 4.30 3.60 3.70 2.90

Annual Metrics And Ratios for Hippo

This table displays calculated financial ratios and metrics derived from Hippo's official financial filings.

Metric 2020 2021 2022 2023 2024
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Growth Metrics		 - - - - -
Revenue Growth		 0.00% 76.74% 31.25% 75.19% 77.44%
EBITDA Growth		 0.00% 39.76% -69.93% 22.08% 98.23%
EBIT Growth		 0.00% 30.99% -52.21% 19.65% 89.56%
NOPAT Growth		 0.00% -83.70% -52.21% 19.65% 68.89%
Net Income Growth		 0.00% -160.18% 11.25% 19.45% 89.13%
EPS Growth		 0.00% -160.18% 57.02% 21.01% 85.84%
Operating Cash Flow Growth		 0.00% -90.37% -29.72% 42.79% 151.41%
Free Cash Flow Firm Growth		 0.00% 0.00% 38.97% -78.76% 99.36%
Invested Capital Growth		 0.00% 124.56% -312.22% 218.34% -100.00%
Revenue Q/Q Growth		 0.00% 0.00% 3.28% 15.86% 0.00%
EBITDA Q/Q Growth		 0.00% 0.00% 1.11% 8.39% 0.00%
EBIT Q/Q Growth		 0.00% 0.00% 0.85% 7.35% 0.00%
NOPAT Q/Q Growth		 0.00% 0.00% 0.85% 7.35% 0.00%
Net Income Q/Q Growth		 0.00% 0.00% -0.34% 7.43% 0.00%
EPS Q/Q Growth		 0.00% 0.00% -1.10% 6.46% 0.00%
Operating Cash Flow Q/Q Growth		 0.00% 16.05% -18.14% -24.86% 0.00%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% -218.07% 0.00%
Invested Capital Q/Q Growth		 0.00% 0.00% -22.45% 137.73% 0.00%
Profitability Metrics		 - - - - -
Gross Margin		 13.57% -38.27% -34.75% -24.37% 19.97%
EBITDA Margin		 -591.67% -201.64% -261.07% -116.12% -1.16%
Operating Margin		 -227.13% -236.07% -273.77% -125.56% -22.01%
EBIT Margin		 -604.65% -236.07% -273.77% -125.56% -7.39%
Profit (Net Income) Margin		 -274.03% -403.40% -272.77% -125.42% -7.69%
Tax Burden Percent		 98.74% 100.19% 100.40% 100.19% 104.38%
Interest Burden Percent		 45.90% 170.55% 99.24% 99.70% 99.64%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% -4,286.28% -206.59%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% -4,270.05% -214.87%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 4,232.51% 198.97%
Return on Equity (ROE)		 -97.32% -73.07% -44.87% -53.77% -7.63%
Cash Return on Invested Capital (CROIC)		 0.00% -1,189.19% 0.00% -516.59% -6.59%
Operating Return on Assets (OROA)		 -31.86% -16.42% -20.41% -17.02% -1.79%
Return on Assets (ROA)		 -14.44% -28.06% -20.33% -17.00% -1.86%
Return on Common Equity (ROCE)		 133.68% -47.89% -44.70% -53.20% -7.53%
Return on Equity Simple (ROE_SIMPLE)		 70.84% -42.80% -55.35% -69.60% -7.90%
Net Operating Profit after Tax (NOPAT)		 -82 -151 -229 -184 -57
NOPAT Margin		 -158.99% -165.25% -191.64% -87.89% -15.41%
Net Nonoperating Expense Percent (NNEP)		 -25.23% -40.41% -13.12% -16.23% 8.27%
Return On Investment Capital (ROIC_SIMPLE)		 - - -38.65% -47.91% -15.70%
Cost of Revenue to Revenue		 86.43% 138.27% 134.75% 124.37% 80.03%
SG&A Expenses to Revenue		 71.32% 53.95% 59.73% 37.96% 19.00%
R&D to Revenue		 34.88% 39.69% 48.04% 22.41% 8.25%
Operating Expenses to Revenue		 240.70% 197.81% 239.01% 101.19% 41.98%
Earnings before Interest and Taxes (EBIT)		 -312 -215 -328 -263 -28
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -305 -184 -313 -244 -4.30
Valuation Ratios		 - - - - -
Price to Book Value (P/BV)		 0.00 1.85 0.53 0.58 1.80
Price to Tangible Book Value (P/TBV)		 0.00 2.13 0.60 0.72 2.20
Price to Revenue (P/Rev)		 3.88 17.46 2.62 1.04 1.75
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 34.16 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 6.00 8.28 0.00 0.00 0.78
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 6.11
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - -
Debt to Equity		 1.88 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 1.88 0.00 0.00 0.00 0.00
Financial Leverage		 -1.62 -1.07 -1.02 -0.99 -0.93
Leverage Ratio		 6.74 2.60 2.21 3.16 4.09
Compound Leverage Factor		 3.09 4.44 2.19 3.15 4.08
Debt to Total Capital		 65.26% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 65.26% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 82.45% 0.24% 0.61% 1.77% 0.85%
Common Equity to Total Capital		 -47.72% 99.76% 99.39% 98.23% 99.15%
Debt to EBITDA		 -0.89 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.77 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 -0.89 0.00 0.00 0.00 0.00
Debt to NOPAT		 -3.33 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 2.87 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 -3.33 0.00 0.00 0.00 0.00
Altman Z-Score		 -0.91 0.55 -1.28 -1.77 -0.89
Noncontrolling Interest Sharing Ratio		 237.37% 34.46% 0.39% 1.06% 1.32%
Liquidity Ratios		 - - - - -
Current Ratio		 2.09 1.63 1.00 0.41 0.53
Quick Ratio		 2.09 1.63 1.00 0.41 0.53
Cash Flow Metrics		 - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -263 -160 -287 -1.83
Operating Cash Flow to CapEx		 -695.74% -882.98% -819.80% -197.86% 395.83%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 -2.52 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 -2.88 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - -
Asset Turnover		 0.05 0.07 0.07 0.14 0.24
Accounts Receivable Turnover		 1.39 1.95 1.46 1.66 2.38
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 2.03
Accounts Payable Turnover		 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)		 262.43 187.30 249.58 219.66 153.12
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)		 262.43 187.30 249.58 219.66 153.12
Capital & Investment Metrics		 - - - - -
Invested Capital		 -90 22 -47 56 0.00
Invested Capital Turnover		 -0.57 -2.69 -9.65 48.77 13.41
Increase / (Decrease) in Invested Capital		 0.00 112 -69 102 -56
Enterprise Value (EV)		 310 755 -323 -105 290
Market Capitalization		 200 1,592 314 218 652
Book Value per Share		 ($2.30) $1.53 $25.58 $15.82 $14.86
Tangible Book Value per Share		 ($3.41) $1.33 $22.73 $12.65 $12.19
Total Capital		 418 862 594 385 365
Total Debt		 273 0.00 0.00 0.00 0.00
Total Long-Term Debt		 273 0.00 0.00 0.00 0.00
Net Debt		 -235 -840 -640 -329 -365
Capital Expenditures (CapEx)		 9.40 14 20 47 12
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -197 -459 -522 -551 -519
Debt-free Net Working Capital (DFNWC)		 255 326 -2.60 -409 -321
Net Working Capital (NWC)		 255 326 -2.60 -409 -321
Net Nonoperating Expense (NNE)		 59 217 97 79 -29
Net Nonoperating Obligations (NNO)		 -235 -840 -640 -329 -365
Total Depreciation and Amortization (D&A)		 6.70 31 15 20 23
Debt-free, Cash-free Net Working Capital to Revenue		 -382.36% -503.40% -436.01% -262.71% -139.48%
Debt-free Net Working Capital to Revenue		 494.19% 357.02% -2.17% -194.95% -86.37%
Net Working Capital to Revenue		 494.19% 357.02% -2.17% -194.95% -86.37%
Earnings Adjustments		 - - - - -
Adjusted Basic Earnings per Share		 $0.00 ($34.00) ($14.66) ($11.58) ($1.64)
Adjusted Weighted Average Basic Shares Outstanding		 0.00 10.89M 22.75M 23.58M 24.70M
Adjusted Diluted Earnings per Share		 $0.00 ($34.00) ($14.66) ($11.58) ($1.64)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 10.89M 22.75M 23.58M 24.70M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 22.65M 23.31M 24.31M 25.08M
Normalized Net Operating Profit after Tax (NOPAT)		 -82 -151 -191 -180 -55
Normalized NOPAT Margin		 -158.99% -165.25% -159.30% -86.06% -14.73%
Pre Tax Income Margin		 -277.52% -402.63% -271.68% -125.18% -7.36%
Debt Service Ratios		 - - - - -
EBIT to Interest Expense		 -12.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 -3.16 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 -12.36 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 -3.52 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - -
Dividend Payout Ratio		 0.00% 0.00% -1.62% -3.65% -71.33%
Augmented Payout Ratio		 0.00% 0.00% -1.62% -4.33% -125.87%

Quarterly Metrics And Ratios for Hippo

This table displays calculated financial ratios and metrics derived from Hippo's official financial filings.

Metric Q2 2022 Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q1 2025
Period end date 6/30/2022 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 9/30/2024 3/31/2025
Growth Metrics		 - - - - - - - - - -
Revenue Growth		 37.32% 44.13% 11.88% 62.45% 66.20% 87.95% 80.17% 113.82% 100.21% 29.61%
EBITDA Growth		 5.41% -418.49% 3.47% -1.28% -46.33% 62.97% 40.51% 56.80% 100.70% -38.60%
EBIT Growth		 14.13% -326.85% 2.19% -1.81% -46.44% 60.22% 35.68% 51.26% 95.05% -38.60%
NOPAT Growth		 -51.58% -126.51% 4.38% -0.30% -45.83% 60.25% 34.21% 51.26% 95.05% -38.60%
Net Income Growth		 13.98% -326.42% -1.85% -2.41% -46.11% 60.55% 34.88% 51.40% 95.06% -37.16%
EPS Growth		 13.98% -326.42% 50.36% 0.00% -41.85% 60.42% 35.02% 51.16% 92.62% -29.93%
Operating Cash Flow Growth		 44.51% 14.00% -467.92% 39.08% 68.79% 102.56% -61.13% 149.58% -13.98% -301.13%
Free Cash Flow Firm Growth		 0.00% 102.37% 0.00% -46.14% -52.69% 3,250.68% -597.67% -16.35% 110.14% -454.45%
Invested Capital Growth		 -90.42% -172.26% -312.22% -311.78% -700.00% -284.07% 218.34% -101.81% -116.92% 106.03%
Revenue Q/Q Growth		 17.14% 6.97% 16.61% 11.17% 19.85% 20.96% 11.79% 31.94% 12.22% 0.00%
EBITDA Q/Q Growth		 -9.29% -80.94% 52.59% -10.68% -57.91% 54.21% 23.85% 21.55% 102.56% 0.00%
EBIT Q/Q Growth		 -8.14% -77.41% 50.86% -10.47% -55.56% 51.81% 20.55% 18.16% 84.19% 0.00%
NOPAT Q/Q Growth		 -6.98% -76.81% 52.00% -10.47% -55.56% 51.81% 20.55% 18.16% 84.19% 0.00%
Net Income Q/Q Growth		 -8.27% -77.08% 52.55% -12.56% -54.48% 52.19% 21.67% 15.99% 84.29% 0.00%
EPS Q/Q Growth		 -8.27% -77.08% 51.06% -8.66% -53.16% 51.41% 19.64% 18.33% 76.87% 0.00%
Operating Cash Flow Q/Q Growth		 49.15% -44.30% 30.00% -18.60% 73.95% 111.83% -4,509.09% 136.49% -159.89% 0.00%
Free Cash Flow Firm Q/Q Growth		 8.98% -98.37% 1,097.72% 153.72% -4.28% 15.20% -277.90% -33.85% 140.45% 0.00%
Invested Capital Q/Q Growth		 -46.30% -295.41% -22.45% -64.82% -52.13% -25.09% 137.73% 2.01% -63.53% 0.00%
Profitability Metrics		 - - - - - - - - - -
Gross Margin		 -62.37% -28.66% -10.34% -34.42% -100.21% 1.56% 14.73% 13.75% 22.30% -11.15%
EBITDA Margin		 -237.63% -401.95% -163.41% -158.79% -209.22% -79.20% -53.95% -32.08% 0.73% -41.34%
Operating Margin		 -250.87% -414.66% -170.67% -169.60% -220.13% -87.70% -62.33% -38.66% -5.45% -41.34%
EBIT Margin		 -249.83% -414.33% -174.58% -169.60% -220.13% -87.70% -62.33% -38.66% -5.45% -41.34%
Profit (Net Income) Margin		 -250.87% -415.31% -168.99% -171.11% -220.55% -87.18% -61.09% -38.90% -5.45% -41.16%
Tax Burden Percent		 100.42% 100.24% 100.83% 100.44% 100.19% 99.41% 100.77% 100.61% 100.00% 99.56%
Interest Burden Percent		 100.00% 100.00% 96.00% 100.44% 100.00% 100.00% 97.26% 100.00% 100.00% 100.00%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 -166.80% -4,577.03% 0.00% 0.00% 0.00% 0.00% -2,127.62% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 -160.90% -4,572.01% 0.00% 0.00% 0.00% 0.00% -2,125.30% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 123.16% 4,528.44% 0.00% 0.00% 0.00% 0.00% 2,106.61% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 -43.64% -48.59% -44.87% -48.55% -60.30% -54.10% -21.01% -50.79% -32.94% -12.02%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -516.59% 0.00% 0.00% -2,464.04%
Operating Return on Assets (OROA)		 -28.60% -29.21% -13.01% -13.96% -20.48% -9.69% -8.45% -6.36% -1.02% -10.82%
Return on Assets (ROA)		 -28.72% -29.28% -12.60% -14.09% -20.52% -9.63% -8.28% -6.40% -1.02% -10.77%
Return on Common Equity (ROCE)		 -34.42% -48.39% -44.70% -48.26% -60.11% -53.67% -20.78% -50.32% -32.73% -11.91%
Return on Equity Simple (ROE_SIMPLE)		 -30.41% -51.24% 0.00% -60.95% -81.08% -69.80% 0.00% -64.92% -39.22% -12.67%
Net Operating Profit after Tax (NOPAT)		 -50 -89 -43 -47 -74 -35 -28 -23 -3.64 -32
NOPAT Margin		 -175.61% -290.26% -119.47% -118.72% -154.09% -61.39% -43.63% -27.06% -3.81% -28.94%
Net Nonoperating Expense Percent (NNEP)		 -5.90% -5.02% -2.40% -2.99% -4.89% -2.41% -2.32% -1.78% -0.27% -3.26%
Return On Investment Capital (ROIC_SIMPLE)		 - - -7.21% - - - -7.31% - - -9.80%
Cost of Revenue to Revenue		 162.37% 128.66% 110.34% 134.42% 200.21% 98.44% 85.27% 86.25% 77.70% 111.15%
SG&A Expenses to Revenue		 63.41% 61.89% 49.72% 49.75% 45.07% 35.88% 27.29% 21.50% 16.02% 14.96%
R&D to Revenue		 57.49% 48.21% 32.12% 29.15% 27.46% 20.62% 16.12% 9.75% 7.33% 7.34%
Operating Expenses to Revenue		 188.50% 385.99% 160.34% 135.18% 119.92% 89.25% 77.05% 52.41% 27.75% 30.19%
Earnings before Interest and Taxes (EBIT)		 -72 -127 -63 -68 -105 -51 -40 -33 -5.20 -46
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -68 -123 -59 -63 -100 -46 -35 -27 0.70 -46
Valuation Ratios		 - - - - - - - - - -
Price to Book Value (P/BV)		 0.67 0.67 0.53 0.70 0.86 0.46 0.58 1.26 1.29 1.99
Price to Tangible Book Value (P/TBV)		 0.79 0.74 0.60 0.80 1.02 0.56 0.72 1.61 1.67 2.47
Price to Revenue (P/Rev)		 4.69 3.66 2.62 2.80 2.50 1.04 1.04 1.74 1.39 1.61
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 34.86
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.82
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -0.77 -0.99 -1.02 -1.03 -1.08 -1.18 -0.99 -1.26 -1.48 -1.22
Leverage Ratio		 1.95 2.13 2.21 2.43 2.76 3.12 3.16 3.45 4.15 4.46
Compound Leverage Factor		 1.95 2.13 2.12 2.44 2.76 3.12 3.08 3.45 4.15 4.46
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.31% 0.63% 0.61% 0.87% 0.31% 1.05% 1.77% 1.01% 1.12% 0.89%
Common Equity to Total Capital		 99.69% 99.37% 99.39% 99.13% 99.69% 98.95% 98.23% 98.99% 98.88% 99.11%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 -0.32 -0.70 -0.72 -0.80 -1.03 -1.07 -1.29 -1.02 -0.78 -1.05
Noncontrolling Interest Sharing Ratio		 21.13% 0.41% 0.39% 0.58% 0.31% 0.79% 1.06% 0.92% 0.66% 0.96%
Liquidity Ratios		 - - - - - - - - - -
Current Ratio		 1.20 1.00 1.00 0.89 0.72 0.72 0.41 0.71 1.05 0.43
Quick Ratio		 1.20 1.00 1.00 0.89 0.72 0.72 0.41 0.71 0.99 0.43
Cash Flow Metrics		 - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 135 2.19 26 67 64 73 -131 56 134 -197
Operating Cash Flow to CapEx		 -662.22% -781.82% -860.00% -915.38% -27.68% 23.40% -1,077.78% 520.59% -278.95% -1,227.59%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - -
Asset Turnover		 0.11 0.07 0.07 0.08 0.09 0.11 0.14 0.16 0.19 0.26
Accounts Receivable Turnover		 0.00 1.54 1.46 1.39 1.43 1.54 1.66 1.77 1.98 2.43
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Payable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)		 0.00 236.35 249.58 263.07 254.55 237.15 219.66 205.69 184.43 150.02
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)		 0.00 236.35 249.58 263.07 254.55 237.15 219.66 205.69 184.43 150.02
Capital & Investment Metrics		 - - - - - - - - - -
Invested Capital		 20 -38 -47 -77 -118 -147 56 -156 -255 9.40
Invested Capital Turnover		 0.95 15.77 -9.65 -6.62 -3.14 -1.95 48.77 -2.19 -1.62 -5.42
Increase / (Decrease) in Invested Capital		 -185 -91 -69 -114 -137 -109 102 -79 -138 165
Enterprise Value (EV)		 -230 -249 -323 -237 -179 -365 -105 -63 -161 328
Market Capitalization		 499 424 314 378 385 189 218 444 421 641
Book Value per Share		 $1.32 $1.11 $25.58 $23.10 $19.15 $17.20 $15.82 $14.45 $13.10 $12.87
Tangible Book Value per Share		 $1.11 $1.00 $22.73 $20.22 $16.20 $14.22 $12.65 $11.36 $10.13 $10.34
Total Capital		 751 639 594 543 447 411 385 355 330 326
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -732 -677 -640 -620 -565 -558 -329 -511 -585 -316
Capital Expenditures (CapEx)		 4.50 5.50 3.50 3.90 34 4.70 4.50 3.40 3.80 2.90
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -515 -571 -522 -554 -650 -631 -551 -551 -553 -557
Debt-free Net Working Capital (DFNWC)		 114 -3.20 -2.60 -74 -221 -214 -409 -203 33 -416
Net Working Capital (NWC)		 114 -3.20 -2.60 -74 -221 -214 -409 -203 33 -416
Net Nonoperating Expense (NNE)		 22 38 18 21 32 15 11 10 1.56 13
Net Nonoperating Obligations (NNO)		 -732 -677 -640 -620 -565 -558 -329 -511 -585 -316
Total Depreciation and Amortization (D&A)		 3.50 3.80 4.00 4.30 5.20 4.90 5.40 5.60 5.90 0.00
Debt-free, Cash-free Net Working Capital to Revenue		 -483.76% -492.92% -436.01% -410.15% -421.95% -348.34% -262.71% -216.24% -182.50% -140.25%
Debt-free Net Working Capital to Revenue		 107.04% -2.76% -2.17% -55.11% -143.38% -118.01% -194.95% -79.73% 10.77% -104.78%
Net Working Capital to Revenue		 107.04% -2.76% -2.17% -55.11% -143.38% -118.01% -194.95% -79.73% 10.77% -104.78%
Earnings Adjustments		 - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($3.25) ($5.66) ($2.77) ($3.01) ($4.61) ($2.24) ($1.80) ($1.47) ($0.34) ($1.91)
Adjusted Weighted Average Basic Shares Outstanding		 22.64M 22.84M 22.75M 23.20M 23.39M 23.73M 23.58M 24.23M 25.07M 24.98M
Adjusted Diluted Earnings per Share		 ($3.25) ($5.66) ($2.77) ($3.01) ($4.61) ($2.24) ($1.80) ($1.47) ($0.34) ($1.91)
Adjusted Weighted Average Diluted Shares Outstanding		 22.64M 22.84M 22.75M 23.20M 23.39M 23.73M 23.58M 24.23M 25.07M 24.98M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 ($2.77) $0.00 $0.00 $0.00 ($1.80) $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 22.89M 23.06M 23.31M 23.26M 23.67M 23.89M 24.31M 24.43M 24.36M 25.16M
Normalized Net Operating Profit after Tax (NOPAT)		 -50 -50 -43 -47 -74 -35 -24 -21 -9.38 -32
Normalized NOPAT Margin		 -175.61% -164.17% -119.47% -118.72% -154.09% -61.39% -37.66% -24.10% -9.82% -28.94%
Pre Tax Income Margin		 -249.83% -414.33% -167.60% -170.35% -220.13% -87.70% -60.62% -38.66% -5.45% -41.34%
Debt Service Ratios		 - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% -1.62% 0.00% -2.63% -3.38% -3.65% -7.28% -10.55% -39.85%
Augmented Payout Ratio		 0.00% 0.00% -1.62% -0.06% -3.13% -4.01% -4.33% -7.98% -10.55% -39.85%

Key Financial Trends

Hippo’s Q1 2025 results show continued top-line growth and aggressive investment but also widening losses and tightening liquidity. Revenue climbed to $110.3 million, up 29.6% year-over-year, driven by higher policy volumes and expanded distribution partners. However, profitability and cash flow metrics remain under pressure as the company invests heavily in technology and underwriting capabilities.

  • Revenue growth remains robust at 29.6% YoY in Q1 2025, with total revenue of $110.3 million.
  • Market capitalization rose to $641 million, up roughly 44% YoY, reflecting investor appetite for growth.
  • Hippo holds a net cash position of $316 million as of Q1 2025, with no net debt on the balance sheet.
  • Invested capital increased by $165 million in Q1 2025, underscoring continued investment in growth initiatives.
  • Valuation remains moderate: P/Revenue ≈ 1.61× and P/Book ≈ 1.99× at quarter end.
  • SG&A and R&D spend steady at 15% and 7.3% of revenue, respectively, indicating disciplined reinvestment.
  • Operating losses persist: NOPAT margin at –28.9% and EBITDA margin at –41.3% in Q1 2025.
  • Cash flow from operations was negative $35.6 million, and free cash flow to firm was –$197.3 million.
  • Gross margin swung to –11.2% in Q1 2025 from +13.7% a year earlier, pressuring underwriting economics.
  • Liquidity ratios are weak, with a current ratio and quick ratio both at 0.43, raising short-term solvency concerns.

Overall, Hippo continues to deliver strong revenue growth and maintains a healthy cash buffer, but investors should monitor its steep losses, margin compression, and liquidity metrics as it scales its insurance platform.

06/21/25 08:25 AMAI Generated. May Contain Errors.

Frequently Asked Questions About Hippo's Financials

When does Hippo's financial year end?

According to the most recent income statement we have on file, Hippo's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Hippo's net income changed over the last 4 years?

Hippo's net income appears to be on a downward trend, with a most recent value of -$28.60 million in 2024, falling from -$141.40 million in 2020. The previous period was -$263 million in 2023. Check out Hippo's forecast to explore projected trends and price targets.

What is Hippo's operating income?
Hippo's total operating income in 2024 was -$81.90 million, based on the following breakdown:
  • Total Gross Profit: $74.30 million
  • Total Operating Expenses: $156.20 million
How has Hippo's revenue changed over the last 4 years?

Over the last 4 years, Hippo's total revenue changed from $51.60 million in 2020 to $372.10 million in 2024, a change of 621.1%.

How much debt does Hippo have?

Hippo's total liabilities were at $1.18 billion at the end of 2024, a 3.4% increase from 2023, and a 41.3% increase since 2020.

How much cash does Hippo have?

In the past 4 years, Hippo's cash and equivalents has ranged from $142.10 million in 2023 to $775.60 million in 2021, and is currently $197.60 million as of their latest financial filing in 2024.

How has Hippo's book value per share changed over the last 4 years?

Over the last 4 years, Hippo's book value per share changed from -2.30 in 2020 to 14.86 in 2024, a change of -747.2%.


Related Companies

This page (NYSE:HIPO) was last updated on 6/21/2025 by MarketBeat.com Staff
From Our Partners
Trump’s Exec Order #14154 could be a “Millionaire-Maker”
Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...
Paradigm Press | Sponsored
An AI run of epic proportions is only getting started
I just put together an urgent new presentation that you need to see right away. In short: I believe we are...
Timothy Sykes | Sponsored
Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...
Porter & Company | Sponsored
Elon’s NEXT Big IPO?
Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...
Banyan Hill Publishing | Sponsored
The Robotics Revolution has arrived … and one $7 stock could take off as a result.
Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...
Weiss Ratings | Sponsored
Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...
Brownstone Research | Sponsored
Top Picks for Trump’s Pro-Crypto America
Mark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…
Crypto 101 Media | Sponsored
The IRS Loophole That Lets You Own Gold Tax-Free
What if I told you there's a legal way to own real physical gold and silver—and keep your gains tax-free? N...
Advantage Gold | Sponsored